adipose-derived regenerative cells
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03269409 | Nov 2017 → Jun 2021 | osteonecrosis | Mayo Clinic | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02904824 | Jul 2012 → Sep 2014 | — | Hospital General Universitario Gregorio Marañon | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT02866565 | Jun 2023 → Sep 2026 expected | ulcer of lower limbs | Assistance Publique Hopitaux De Marseille | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT03776721 | Dec 2018 → Jun 2021 | lymphedema | Odense University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT07355530 | Jan 2018 → Mar 2021 | — | Odense University Hospital | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02529865 | Jul 2015 → Mar 2019 | female stress incontinence | Nagoya University | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT03503305 | Nov 2018 → Mar 2026 overdue | osteoarthritis | InGeneron, Inc. | Active not recruiting | No outcome recorded |
| — | NCT02918136 | Dec 2016 → Jul 2018 | rotator cuff syndrome | InGeneron, Inc. | Completed | No outcome recorded |
| — | NCT02987101 | Nov 2016 → Jun 2018 | ulcer of lower limbs | Odense University Hospital | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adipose-derived regenerative cells | “Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the...” NCT02529865 ↗9“Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the...” NCT02529865 ↗ “The focus of this study is to investigate the therapeutic benefit of autologous adipose-derived regenerative cells in patients with wrist arthritis.” NCT03503305 ↗ “using adipose-derived regenerative cells (ADRCs) and lipotransfer in alleviating BCRL through regeneration of lymphatic tissue” PMID 39591365 ↗ Feb 2024 |
| Known as | ADRC | “Subjects in this arm will have Adipose Derived Regenerative Cells (ADRC)harvested through autologous liposuction and processed outside the body using The Celution 800/GP System...” NCT03269409 ↗1“ADRC, adipose derived regenerative cells” NCT02904824 ↗ |
| Known as | ADRCs | “Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the...” NCT02529865 ↗4“Subjects in the treated group will receive an Adipose derived regenerative cells (ADRCs) injection into the wrist using a fluoroscopic-guided injection .” NCT03503305 ↗ “using adipose-derived regenerative cells (ADRCs) and lipotransfer in alleviating BCRL through regeneration of lymphatic tissue” PMID 39591365 ↗ Feb 2024 “Early data suggest that enriching fat grafts with adipose-derived regenerative cells (ADRCs) promote angiogenesis” PMID 29760737 ↗ Apr 2018 “adipose-derived regenerative cells (ADRCs)” NCT02866565 ↗ |
| Modality | Cell therapy | “periurethral injection of autologous regenerative cells from adipose tissue” PMID 28946874 ↗ Sep 2017 |
| Route | Other | “periurethral injection of autologous ADRCs and adipose tissue” NCT02529865 ↗ |